Chemical Structure : PW164
Catalog No.: PC-25069Not For Human Use, Lab Use Only.
PW164 is a specific, small molecule inhibitor of FGF13/Nav1.7 channel C-terminal tail domain (CTD) PPI interface with IC50 of 29 uM (FGF13/Nav1.7 complex assembly), selectively modulates Nav1.7 currents.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PW164 is a specific, small molecule inhibitor of FGF13/Nav1.7 channel C-terminal tail domain (CTD) PPI interface with IC50 of 29 uM (FGF13/Nav1.7 complex assembly), selectively modulates Nav1.7 currents.
PW164 selectively suppresses capsaicin-induced signaling in hIPSC-derived sensory neurons.
PW164 displays appreciable binding for FGF13 (KD of 21 μM) but shows no interaction with Nav1.7 CTD.
PW164 reverses FGF13-induced increase in INa density dose dependently, with an IC50 of 6.74 μM and induces LTI while decelerating Nav1.7 repriming.
PW164 is an FGF13-dependent analgesic that preserves normal sensory function, exerts antinociceptive effects and mimics in vivo FGF13 knockdown.
PW164 (15 mg/kg, i.d.) reduces mechanical hyperalgesia in the HFD-induced T2DN mouse model.
M.Wt | 660.81 | |
Formula | C34H52N4O9 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Singh AK, et al. J Clin Invest. 2025 Jul 15;135(14):e183749.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright